PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 22, Issue 7, Pages 927-932
Publisher
Informa Healthcare
Online
2013-05-21
DOI
10.1517/13543784.2013.801958
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
- (2012) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Moxifloxacin for tuberculosis
- (2012) Kasha Priya Singh et al. LANCET INFECTIOUS DISEASES
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents
- (2011) A.H. Diacon et al. CLINICAL MICROBIOLOGY AND INFECTION
- New regimens for reducing the duration of treatment of drug-susceptible pulmonary tuberculosis
- (2011) Marcus B. Conde et al. DRUG DEVELOPMENT RESEARCH
- Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
- (2011) A. H. Diacon et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- The challenge of new drug discovery for tuberculosis
- (2011) Anil Koul et al. NATURE
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
- (2010) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
- (2010) Robert S Wallis et al. LANCET
- Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824
- (2008) Xiaojin Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search